Mark Robert Keaton
Mark Robert Keaton publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research and Breast Cancer Treatment Studies.
- World rank
- #3,025,664 of 7,710,434 ranked researchers
- Rank in United States
- #867,465 of 1,627,098
- Works
- 32
- Citations
- 991
- Citations per work
- 31.0
What does Mark Robert Keaton research?
Mark Robert Keaton's work is mostly in Medicine (76%), Biochemistry, Genetics and Molecular Biology (16%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2475.7%
- Medicine2475.7%
- Life Sciences516.1%
- Everything else38.2%
- 1Oncology55% of their works
- 2Pulmonary and Respiratory Medicine18% of their works
- 3Cancer Research13% of their works
- 4Cardiology and Cardiovascular Medicine3% of their works
- 5Cell Biology2% of their works
- 6Molecular Biology2% of their works
Research topics
Which keywords describe Mark Robert Keaton's research?
The keywords of their largest research topics: Chemotherapy, Metastatic Breast Cancer, Breast Cancer, Molecular Subtypes, Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Trastuzumab and EGFR.
- Anthracyclines
- Genomic Profiles
- EGFR Mutations
- ALK Inhibitors
- Cetuximab
- Gene Expression
- Breast Tumours
- EGFR
- Taxanes
- Molecular Subtypes
- Metastatic Breast Cancer
- Chemotherapy
- Breast Cancer
- Chemotherapy-Induced Peripheral Neuropathy
- Trastuzumab
- HER2
- Clinical Trials
- Targeted Therapy
- KRAS Mutations
- CDK4/6 Inhibitors
- Palbociclib
- Small-Cell Lung Cancer
- Doxorubicin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Chemotherapy214 topics
- Metastatic Breast Cancer182 topics
- Breast Cancer152 topics
- Molecular Subtypes142 topics
- Chemotherapy-Induced Peripheral Neuropathy131 topic
- Taxanes131 topic
- Trastuzumab122 topics
- EGFR101 topic
- HER2101 topic
- Breast Tumours81 topic
- Clinical Trials82 topics
- Gene Expression81 topic
- Targeted Therapy82 topics
- Cetuximab61 topic
- KRAS Mutations61 topic
- ALK Inhibitors51 topic
- CDK4/6 Inhibitors51 topic
- EGFR Mutations51 topic
- Palbociclib51 topic
- Genomic Profiles31 topic
- Small-Cell Lung Cancer31 topic
- Anthracyclines21 topic
- Doxorubicin21 topic
Where does Mark Robert Keaton work?
Mark Robert Keaton's main affiliation in the publication record is Sarah Cannon, United States.
How many publications and citations does Mark Robert Keaton have?
OpenAlex counts 32 works and 991 citations for Mark Robert Keaton, an h-index of 10, ranking #3,025,664 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark Robert Keaton. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.